HPV and cervical cancer in the 2007 report.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 18068032)

Published in Vaccine on November 01, 2007

Authors

WHO/ICO Information Centre on HPV and Cervical Cancer

Articles citing this

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer (2012) 1.66

VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus. PLoS One (2012) 1.07

Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. J Clin Virol (2009) 1.05

Development of therapeutic HPV vaccines. Lancet Oncol (2009) 1.04

Awareness of HPV and cervical cancer prevention among Cameroonian healthcare workers. BMC Womens Health (2011) 1.02

Distribution patterns of infection with multiple types of human papillomaviruses and their association with risk factors. PLoS One (2011) 0.91

Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model. BMC Infect Dis (2012) 0.87

Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study. Hum Vaccin Immunother (2014) 0.86

Differences in patterns of high-risk human papillomavirus infection between urban and rural low-resource settings: cross-sectional findings from Mali. BMC Womens Health (2013) 0.84

Prevalence and Genotype Distribution of HPV Infection in China: Analysis of 51,345 HPV Genotyping Results from China's Largest CAP Certified Laboratory. J Cancer (2016) 0.84

High-risk cervical human papillomavirus infections among human immunodeficiency virus-positive women in the Bahamas. PLoS One (2014) 0.83

Laboratory and clinical aspects of human papillomavirus testing. Crit Rev Clin Lab Sci (2012) 0.80

Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth. Sex Transm Dis (2015) 0.80

Human papillomavirus genotypes in cervical cancer and vaccination challenges in Zimbabwe. Infect Agent Cancer (2014) 0.78

Role of hospital-based cancer registries: a decade of experience of cancer cervix from a tertiary care centre, India. Indian J Community Med (2014) 0.78

Segmentary ureteral resection followed by ureteroneocystostomy associated with radical hysterectomy and partial cystectomy in a patient with bulky residual disease after chemoirradiation for invasive cervical cancer--a case report. J Med Life (2015) 0.75

The Prevalence and Genotype Distribution of Human Papillomavirus in the Genital Tract of Males in Iran. Jundishapur J Microbiol (2015) 0.75

A Low-Cost HPV Immunochromatographic Assay to Detect High-Grade Cervical Intraepithelial Neoplasia. PLoS One (2016) 0.75

Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus. Hum Vaccin Immunother (2017) 0.75